Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Valspring Capital is an active healthcare-focused growth equity investment firm founded in 2022 by the former healthcare investment team of Bain Capital Ventures. The company closed its debut fund at $255 million in January 2025 and invests primarily in growth-stage companies within the healthcare sector, focusing on information technology, technology-enabled services, and related services. Recent investments include HealthJoy (a benefits navigation platform for employers), Phoenix (a Canadian pharmaceuticals home delivery company), and Koala Health (pet health medication delivery).
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Valspring Capital.